Ask an Expert

Question of the Day

Eric J. Nestler, M.D., Ph.D. - Brain & behavior research expert on depression
September 11, 2013

Several rapidly acting antidepressants are currently in clinical trial, such as ketamine (see 2011 Highlights, Dr. Zarate, on p.2). These rapidly acting agents have novel mechanisms compared to currently available antidepressants and could offer significant improvement to patients who do not fully respond to today's medications. In addition, efforts continue to identify even more antidepressant medications with novel mechanisms of action.

 

Eric J. Nestler, M.D., Ph.D.
Scientific Council Member
Nash Family Professor of Neuroscience
Chair, Department of Neuroscience
Director, Friedman Brain Institute
Mount Sinai School of Medicine

Eric R. Kandel, M.D. - Brain and behavior research expert on alzheimer's
Q What is the main difference between dementia and Alzheimer’s disease?
A Dementia is a cognitive impairment that interferes with daily living and... More >
Katherine L. Wisner, M.D.
Q What would recovery from depression look like?
A “A woman who is back to her pre-Depression symptom level, with the ability... More >